Disappointment For Novartis As England’s NICE Says No To Migraine Drug Again

Doubts linger over Aimovig's cost effectiveness

 
• By Neena Brizmohun
  
Headache
NICE has denied funding for migraine prevention drug Aimovig • Source: Shutterstock

More from United Kingdom

More from Europe